ABCL
NASDAQ · Life Sciences Tools & Services
Abcellera Biologics Inc
$5.85
+0.11 (+1.92%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+666.0% upside
Low Target
$32.90
Average Target
$44.81
High Target
$56.58
Current Price
$5.85
Current
$5.85
$5.85
Target
$44.81
$44.81
$32.90
$44.81 avg
$56.58
Scenario Analysis
Bear Case
$32.90
462.4%
Low target
Base Case
$44.81
+666.0%
Avg target
Bull Case
$56.58
+867.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$6.79
-13.8% from high
52-Week Low
$2.75
+113.1% from low
50-Day SMA
$3.99
+46.6% vs SMA
RSI (14)
58.5
Neutral
Target vs 52W High
$44.81
+559.9% vs high
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 34 | 85% | $369.21 | -21.3% |
| DHR | Strong Buy | 30 | 90% | $158.11 | -11.7% |
| A | Strong Buy | 28 | 79% | $64.69 | -48.9% |
| WAT | Buy | 28 | 57% | $189.60 | -46.9% |
| IQV | Strong Buy | 30 | 80% | $82.96 | -51.6% |
| ILMN | Buy | 28 | 61% | $169.36 | +2.7% |
| WST | Strong Buy | 22 | 82% | $136.24 | -59.5% |
| MTD | Hold | 20 | 50% | $170.43 | -85.3% |